2Goadsby PJ,Lipton RB,Ferrari MD.Migraine-current understanding and treatment[J].N Engl J Med,2002,346(4):257-270.
3Ashina M,Bendtsen L,Jensen R,et al.Evidence for increased plasma levels of calcitonin gene-related peptide in migraine outside of attacks[J].Pain,2000,86 (1-2):133-138.
4Bellamy J,Bowen EJ,Russo AF,et al.Nitric oxide regulation of calcitonin gene-related peptide gene expression in rat trigeminal ganglia neurons[J].Eur J Neurosci,2006,23(8):2057-2066.
5Tronvik E,Stovner LJ,Helde G,et al.Prophylactic treatment of migraine with an angiotensin Ⅱ receptor blocker:a randomized controlled trial[J].JAMA,2003,289 (1):65-69.
6Kowa H,Fusayasu E,Ijiri T,et al.Association of the insertion/deletion polymorphism of the angiotensin I-converting enzyme gene in patients of migraine with aura[J].Neurosci Lett,2005,374(2):129-131.
7de Hoon JN,Smits P,Troost J,et al.Forearm vascular response to nitric oxide and calcitonin gene-related peptide:comparison between migraine patients and control subjects[J].Cephalalgia,2006,26(1):56-63.
9Williamson DJ,Hargreaves RJ.Neurogenic inflammation in the context of migraine[J].Microsc Res Tech,2001,53(3):167-178.
10Paterna S,Di Pasquale P,D' Angelo A,et al.Angiotensinconverting enzyme gene deletion polymorphism determines an increase in frequency of migraine attacks in patients sufferingfrom migraine without aura[J].Eur Neurol,2000,43(3):133-136.
